ストックスクリーナーアプリを入手
14.58
10.20%
1.35
プレマーケット:
14.17
-0.41
-2.81%
前日終値:
$13.23
開ける：
$13.03
24時間の取引高:
2.88M
Relative Volume:
1.69
時価総額：
$686.57M
収益：
$217.11M
当期純損益:
$-651.19M
株価収益率:
-1.1224
EPS:
-12.99
ネットキャッシュフロー:
$-387.26M
1週間 パフォーマンス:
+18.06%
1か月 パフォーマンス:
+15.07%
6か月 パフォーマンス:
+155.79%
1年 パフォーマンス:
+78.90%
1日の値動き範囲:
$12.94
$14.62
1週間の範囲:
$10.82
$14.62
52週間の値動き範囲:
$5.00
$16.85
Ginkgo Bioworks Holdings Inc Stock (DNA) Company Profile
名前
Ginkgo Bioworks Holdings Inc
セクター
電話
(877) 442-5362
住所
27 DRYDOCK AVENUE, BOSTON
DNA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
DNA
Ginkgo Bioworks Holdings Inc
|
14.58 | 783.21M | 217.11M | -651.19M | -387.26M | -12.99 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.64 | 101.35B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.00 | 58.66B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
562.27 | 59.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
737.56 | 44.01B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
340.70 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Ginkgo Bioworks Holdings Inc Stock (DNA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-05-15 | ダウングレード | BTIG Research | Neutral → Sell |
| 2024-05-10 | ダウングレード | William Blair | Mkt Perform → Underperform |
| 2023-11-14 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2023-11-09 | ダウングレード | BTIG Research | Buy → Neutral |
| 2023-06-02 | ダウングレード | Goldman | Neutral → Sell |
| 2023-05-11 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2022-11-29 | 開始されました | Berenberg | Buy |
| 2022-10-04 | 開始されました | Morgan Stanley | Equal-Weight |
| 2022-05-18 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2022-03-02 | 再開されました | Cowen | Outperform |
| 2022-02-23 | 開始されました | Goldman | Neutral |
| 2022-02-01 | 開始されました | BofA Securities | Neutral |
| 2022-01-28 | 開始されました | BofA Securities | Buy |
| 2022-01-07 | 開始されました | BTIG Research | Buy |
| 2021-11-29 | 開始されました | Jefferies | Buy |
| 2021-10-13 | 開始されました | Raymond James | Outperform |
| 2021-10-12 | 開始されました | William Blair | Outperform |
| 2021-09-20 | 開始されました | HSBC Securities | Buy |
すべてを表示
Ginkgo Bioworks Holdings Inc (DNA) 最新ニュース
Why Ginkgo Bioworks Holdings Inc. stock could benefit from AI revolutionEarnings Risk Summary & Expert Curated Trade Ideas - newser.com
How Ginkgo Bioworks Holdings Inc. Class stock behaves in tightening cyclesInsider Selling & Expert-Curated Trade Recommendations - newser.com
Will Ginkgo Bioworks Holdings Inc. Class stock benefit from sector leadershipEarnings Risk Summary & Free Weekly Watchlist of Top Performers - newser.com
Risk vs reward if holding onto Ginkgo Bioworks Holdings Inc.2025 Price Action Summary & Detailed Earnings Play Alerts - newser.com
Biochemicals Global Market Report 2026-2036: From ADM and BASF to Startups Like Ginkgo Bioworks: Biochemicals Market to Revolutionize Chemical Industry by 2036 - Yahoo Finance
Using AI based signals to follow Ginkgo Bioworks Holdings Inc.July 2025 Trade Ideas & Fast Exit and Entry Strategy Plans - newser.com
Can Ginkgo Bioworks Holdings Inc. stock outperform in 2025 bull marketWeekly Risk Summary & Daily Oversold Stock Bounce Ideas - newser.com
Ginkgo Bioworks Holdings Inc Stock Analysis and ForecastMonthly Performance Summary & Minimal Capital Trading - earlytimes.in
What analysts say about Ginkgo Bioworks Holdings Inc stockIndustrial Stocks Review & Exceptional Growth Investment - earlytimes.in
What drives Ginkgo Bioworks Holdings Inc stock priceFibonacci Retracement Levels & Small Budget Capital Investment - Early Times
Twist Bioscience and Ginkgo Bioworks update 2022 partnership - MSN
Ginkgo Bioworks (NYSE:DNA) Trading Down 6.2%Here's What Happened - MarketBeat
Ginkgo Bioworks Holdings, Inc. (DNA) Advances While Market Declines: Some Information for Investors - sharewise.com
How to track smart money flows in Ginkgo Bioworks Holdings Inc.Product Launch & Fast Exit and Entry Strategy Plans - newser.com
A-Alpha Bio Appoints Troy Lionberger as New Chief Business Officer to Drive Next Phase of Growth - GlobeNewswire Inc.
Goldman Sachs Group Inc. Has $3.92 Million Stock Position in Ginkgo Bioworks Holdings, Inc. $DNA - MarketBeat
Ginkgo Bioworks Enters Sales Agreement for Stock Offering - MSN
How volatile is Ginkgo Bioworks Holdings Inc stock2025 Retail Activity & Precise Swing Trade Alerts - خودرو بانک
MACD Signal: Will Ginkgo Bioworks Holdings Inc. benefit from current market trends2025 Earnings Surprises & Growth Focused Entry Point Reports - khodrobank.com
Breakout Zone: Is Ginkgo Bioworks Holdings Inc a cyclical or defensive stockPrice Action & Scalable Portfolio Growth Ideas - khodrobank.com
Aug Weekly: How cyclical is Ginkgo Bioworks Holdings Incs revenue streamMarket Sentiment Review & Fast Exit and Entry Trade Guides - خودرو بانک
Investor Mood: Can New York Mortgage Trust Inc Preferred Security be recession proofJuly 2025 Snapshot & Capital Efficiency Focused Ideas - خودرو بانک
Treasury Yields: Will Ginkgo Bioworks Holdings Inc benefit from rising consumer demandWeekly Trade Recap & Verified Entry Point Detection - خودرو بانک
Aug Gainers: Can Ginkgo Bioworks Holdings Inc maintain sales growth2025 Short Interest & AI Driven Price Predictions - khodrobank.com
Aug Sentiment: Is Ginkgo Bioworks Holdings Inc stock forming a cup and handleQuarterly Trade Report & Community Verified Watchlist Alerts - خودرو بانک
Market Overview: Can Ginkgo Bioworks Holdings Inc. sustain earnings growthQuarterly Portfolio Summary & Verified Technical Trade Signals - خودرو بانک
Ginkgo Bioworks (NYSE:DNA) Trading Down 3.5%What's Next? - MarketBeat
Aug Rallies: How cyclical is Ginkgo Bioworks Holdings Incs revenue stream2025 Price Action Summary & AI Powered Market Entry Ideas - خودرو بانک
Growth Value: What are the future prospects of Ginkgo Bioworks Holdings IncJuly 2025 Catalysts & Expert Curated Trade Setups - خودرو بانک
Dividend Watch: Can Ginkgo Bioworks Holdings Inc maintain sales growthJuly 2025 Short Interest & Risk Adjusted Buy and Sell Alerts - خودرو بانک
Take Profit: Does Ginkgo Bioworks Holdings Inc have strong fundamentalsPortfolio Performance Report & Momentum Based Trading Signals - خودرو بانک
Fed Meeting: Will Ginkgo Bioworks Holdings Inc benefit from rising consumer demandPortfolio Update Summary & Safe Entry Zone Identification - خودرو بانک
Risks Report: Will Edible Garden AG Incorporated Equity Warrant outperform small cap indexesJuly 2025 Big Picture & Short-Term High Return Strategies - خودرو بانک
Inflation Data: Is Ginkgo Bioworks Holdings Inc. a strong candidate for buy and hold2025 Market WrapUp & AI Powered Buy/Sell Recommendations - خودرو بانک
Risk Off: What dividend growth rate does Ginkgo Bioworks Holdings Inc offerRecession Risk & Fast Gain Stock Tips - خودرو بانک
Insider Sell: How cyclical is Ginkgo Bioworks Holdings Incs revenue streamSwing Trade & Detailed Earnings Play Alerts - خودرو بانک
Aug Spikes: What are Ginkgo Bioworks Holdings Incs recent SEC filings showingQuarterly Performance Summary & Free High Return Stock Watch Alerts - خودرو بانک
Panic Selling: Will Ginkgo Bioworks Holdings Inc benefit from rising consumer demandJuly 2025 Volume & Weekly Return Optimization Plans - خودرو بانک
Loss Report: Does AdaptHealth Corp stock have upside surprise potentialMarket Activity Report & Scalable Portfolio Growth Methods - خودرو بانک
Ginkgo outlines $250M cost reduction target and tools expansion in Q1 2025 update - MSN
This Ginkgo Bioworks Holdings Insider Reduced Their Stake By 45% - simplywall.st
American Century Companies Inc. Makes New Investment in Ginkgo Bioworks Holdings, Inc. $DNA - MarketBeat
Cubist Systematic Strategies LLC Buys 287,221 Shares of Ginkgo Bioworks Holdings, Inc. $DNA - MarketBeat
Invesco Ltd. Grows Stock Position in Ginkgo Bioworks Holdings, Inc. $DNA - MarketBeat
Ginkgo Bioworks enters into $100M equity sales deal - MSN
EcoR1 Capital LLC Sells 281,016 Shares of Ginkgo Bioworks Holdings, Inc. $DNA - MarketBeat
Ginkgo Bioworks Holdings Inc. Chart Enters High Volatility ZoneTake Profit & High Yield Equity Trading Tips - classian.co.kr
Ginkgo Bioworks Holdings Inc (DNA) 財務データ
収益
当期純利益
現金流量
EPS
2.36%
1.10%
大文字化:
|
ボリューム (24 時間):